Scarica l'app Stockscreener
30.88
5.64%
1.65
Dopo l'orario di chiusura:
30.76
-0.12
-0.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$29.23
Aprire:
$29.61
Volume 24 ore:
1.64M
Relative Volume:
1.49
Capitalizzazione di mercato:
$12.92B
Reddito:
$6.18B
Utile/perdita netta:
$626.40M
Rapporto P/E:
21.52
EPS:
1.435
Flusso di cassa netto:
$848.81M
1 W Prestazione:
+6.15%
1M Prestazione:
+12.29%
6M Prestazione:
-5.68%
1 anno Prestazione:
-16.92%
Intervallo 1D:
$29.60
$30.89
Intervallo di 1 settimana:
$28.69
$30.89
Portata 52W:
$26.12
$37.51
Smith Nephew Plc Adr Stock (SNN) Company Profile
Nome
Smith Nephew Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare SNN vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
30.88 | 12.92B | 6.18B | 626.40M | 848.81M | 1.435 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2026-09-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2026-08-31 | Iniziato | BTIG Research | Neutral |
| 2026-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2026-08-05 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-06-04 | Downgrade | Kepler | Buy → Hold |
| 2025-12-15 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-14 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-03-12 | Downgrade | UBS | Buy → Neutral |
| 2024-11-06 | Downgrade | Berenberg | Buy → Hold |
| 2024-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Iniziato | Deutsche Bank | Buy |
| 2024-06-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-11-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2023-10-13 | Iniziato | Stifel | Hold |
| 2023-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2023-04-27 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-04-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Iniziato | Citigroup | Buy |
| 2022-11-28 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-04 | Aggiornamento | Redburn | Sell → Neutral |
| 2021-06-09 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Iniziato | Barclays | Overweight |
| 2020-07-29 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Downgrade | Citigroup | Buy → Neutral |
| 2019-11-21 | Iniziato | Citigroup | Buy |
| 2019-11-12 | Iniziato | Bernstein | Outperform |
| 2019-07-23 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-02-08 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-27 | Downgrade | Goldman | Buy → Neutral |
| 2017-01-19 | Iniziato | HSBC Securities | Hold |
| 2016-12-08 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Downgrade | Berenberg | Buy → Hold |
| 2016-02-26 | Iniziato | Cantor Fitzgerald | Hold |
Mostra tutto
Smith Nephew Plc Adr Borsa (SNN) Ultime notizie
REGSmith & Nephew PlcSterling Amount of Dividend - TradingView
SMITH & NEPHEW PLC R (NPW1.HM) Q4 FY2025 earnings call transcript - Yahoo Finance
Smith & Nephew PLC (NPW1.HM) insider ownership and holdings - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) stock historical prices and data - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) valuation measures and financial statistics - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) company profile and facts - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) analyst ratings, estimates and forecasts - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) stock major holders - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) stock price, news, quote and history - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) income statement - Yahoo Finance UK
Smith & Nephew PLC (NPW1.HM) options chain - Yahoo Finance UK
SMITH & NEPHEW PLC R (NPW1.HM) Q2 FY2026 earnings call transcript - Yahoo Finance
Smith & Nephew (NYSE:SNN) Looks Like a Decent Value Stock - ChartMill
NPW1.HM Interactive Stock Chart | SMITH & NEPHEW PLC R Stock - Yahoo Finance
Smith & Nephew SNATS, Inc. (SNN) Stock Forecasts - Yahoo Finance
Smith & Nephew PLC (NPW1.HM) stock price, news, quote and history - Yahoo Finance UK
Blue-Chip Stock Smith & Nephew (LSE:SN.) Cuts Sales Outlook: What It Means - Kalkine Media
Smith & Nephew plc (NPW1.DE) insider ownership and holdings - Yahoo Finance UK
FTSE 100 Smith & Nephew (LSE:SN.): Outlook and Dividend - Kalkine Media
A Look at Smith & Nephew PLC (SNN) After 4.3% Gain -- GF Value $30.88 vs Price $29.09 - GuruFocus
Why Is Smith & Nephew (LSE:SN.) Stock Under Scrutiny After Cutting Its Sales Outlook? - Kalkine Media
SMITH & NEPHEW PLC (SN1N.MX) Q2 FY2026 earnings call transcript - Yahoo Finance
Smith & Nephew plc Completes the Pricing of USD 700,000,000 5.750% Notes Due 2036 - marketscreener.com
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
A November 4 analyst call will follow Smith & Nephew (SNN)'s Q3 trading report. - Stock Titan
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal - GlobeNewswire Inc.
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo. - GlobeNewswire Inc.
A five-year trial found better knee pain relief with a cartilage implant than standard surgery. - Stock Titan
Smith & Nephew Launches CartiHeal Cartilage Repair Implant in Europe - Yahoo Finance
5.150% notes due 2027 are named in Smith & Nephew (NYSE: SNN)'s NYSE removal notice. - Stock Titan
Smith & Nephew PLC's Dividend Analysis - Yahoo Finance
Smith & Nephew stock hits 52-week low at 26.39 USD - Investing.com Nigeria
Smith & Nephew plc Announces Redemption Price of $350,000,000 5.150% Notes Due 2027 - marketscreener.com
837M shares carry votes at Smith & Nephew (SNN). Another 40.3M shares are held in treasury. - Stock Titan
The 5.150% notes due in 2027 will be redeemed by Smith & Nephew (SNN) on October 5. - Stock Titan
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Yahoo Finance
AlphaValue/Baader Europe Downgrades Smith & Nephew to Add - marketscreener.com
Smith & Nephew: Estimates reset after guidance cut - marketscreener.com
Smith & Nephew (LSE:SN) Rolls Out EVOS PELVIC This Week: Can It Lift Its Orthopaedic Trauma Game? - Kalkine Media
Smith & Nephew stock faces a Q2 revenue miss - AD HOC NEWS
Smith and Nephew stock falls 0.24 percent ahead of the open - AD HOC NEWS
Smith & Nephew stock trades near its yearly low - AD HOC NEWS
Smith+Nephew Launches the New Evos? Pelvic Plating System - marketscreener.com
One system combines plates, screws and tools for complex pelvic fracture surgery - Stock Titan
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System - markets.businessinsider.com
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical case of LANDMARK◊ Total Knee System - Ortho Spine News
This shoulder implant has been used in more than 250,000 procedures. Smith+Nephew will showcase it. - Stock Titan
Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unveiling a 19% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
New LSE share admission takes Smith & Nephew (NYSE: SNN) to 877,750,024 shares - Stock Titan
Smith Nephew Plc Adr Azioni (SNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):